There are several types of triple agonists currently being studied, but the one closest to FDA approval is retatrutide
This is for several reasons
Further, both studies highlighted the peptide's relative safety, noting the absence of adverse effects typically seen with hGH administration, such as increased IGF-1 levels and reduced glucose tolerance [2]
2.6 Preparation of aortic tissue After euthanizing mice from different groups using gas anesthesia, the thoracic aorta was surgically excised
The funding institution had no involvement in study design, data collection, data analysis, data interpretation, or manuscript preparation
However, semaglutide is well-established with proven results in both diabetes management and weight loss, while retatrutide is still in development stages and not widely available